LitAlert ~~ GeneLit.com

    • Healthcare Disparities and the Demand for Expanding Hereditary Breast Cancer Screening Guidelines in African Americans.
    • Ciuro J, Beyer A, Fritzler J, Jackson N, Ahsan S.
    • Clin Breast Cancer. 2020 Sep 2:S1526-8209(20)30215-9. doi: 10.1016/j.clbc.2020.08.010. Epub ahead of print.
    • Mutations in ATM, NBN and BRCA2 predispose to aggressive prostate cancer in Poland.
    • Wokolorczyk D, Kluzniak W, Huzarski T, Gronwald J, Szymiczek A, Rusak B, Stempa K, Gliniewicz K, Kashyap A, Morawska S, Debniak T, Jakubowska A, Szwiec M, Domagala P, Lubinski J, Narod SA, Akbari MR, Cybulski C; Polish Hereditary Prostate Cancer Consortium.
    • Int J Cancer. 2020 Sep 1. doi: 10.1002/ijc.33272. Epub ahead of print.
    • PARP Inhibitors in Biliary Tract Cancer: A New Kid on the Block?
    • Ricci AD, Rizzo A, Bonucci C, Tober N, Palloni A, Mollica V, Maggio I, Deserti M, Tavolari S, Brandi G.
    • Medicines (Basel). 2020 Aug 31;7(9):E54. doi: 10.3390/medicines7090054.
    • Prevalence and clinical implications of germline predisposition gene mutations in patients with acute myeloid leukemia.
    • Kim B, Yun W, Lee ST, Choi JR, Yoo KH, Koo HH, Jung CW, Kim SH.
    • Sci Rep. 2020 Aug 31;10(1):14297. doi: 10.1038/s41598-020-71386-z.
    • Identification of Recurrent Variants in BRCA1 and BRCA2 across Multiple Cancers in the Chinese Population.
    • Jiang Y, Tian T, Yu C, Zhou W, Yang J, Wang Y, Wen Y, Chen J, Dai J, Jin G, Ma H, Shen H, Hu Z.
    • Biomed Res Int. 2020 Aug 15;2020:6739823. doi: 10.1155/2020/6739823.